US Patent 6958335 Treatment of gastrointestinal stromal tumors
Patent 6958335 was granted and assigned to Novartis on October, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+243 characters)
Article
Patent abstract
4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula Ior a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Brian Jay Druker0
David Tuveson0
Elisabeth Buchdunger0
George Daniel Demetri0
Heikki Joensuu0
Jonathan A. Fletcher0
Michael C. Heinrich0
Renaud Capdeville0
Sandra Leta Silberman0
Sasa Dimitrijevic0
Date of Patent
October 25, 2005
0Patent Application Number
104150150
Date Filed
October 26, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6958335 Treatment of gastrointestinal stromal tumors
Find more entities like US Patent 6958335 Treatment of gastrointestinal stromal tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
